Resilience

That's a wrap on a great week at Biomanufacturing World Summit in San Diego! Here's a quick recap of our busy week: 📍 Thank you to those who joined us for a site tour of our San Diego facility to learn about our cutting-edge capabilities in the development and manufacturing of life-saving therapies. 🔹 Pat Yang, Vice Chairman & Co-Founder of Resilience, closed out the conference with fellow industry leaders Timothy Moore, Executive Vice President, Chief Technical Officer at Allogene, Michael Thien, Senior Vice President & Head, Pharmaceutical Sciences Takeda R&D, Hari Pujar, Chief Operating Officer & Operating Partner at Tessera Therapeutics & Flagship Pioneering, with moderator Alison Moore, Chief Technical Officer at Codexis, during a panel discussion on "Reflecting on the Past, Envisioning the Future: Shaping the Future Landscape of Biomanufacturing." 📣 Lisa Sykes-Winstead MBA, MSc, CQA presented during the lunch session on "Modernizing the Pharma Quality System: What is It and Does It Drive Results?" 👋 Our team enjoyed making new connections and seeing old friends at our booth. If you missed us at the conference, there are still lots of opportunities to connect with our team! https://hubs.ly/Q02ZcBlL0

We are excited to share that Adam Mendez, Head of Data Engineering & Architecture at Resilience, has been invited to present at the AWS re:INVENT conference in Las Vegas, Nevada, on December 4th. In his presentation, Adam will discuss how he and the Resilience team utilized AWS DataSync to develop a global system for lab data connectivity. This system enables near-real-time uploads of data from over 250 laboratory instruments across eight sites, making it instantly searchable and accessible to our scientists, ultimately accelerating data sharing with clients, providing them with timely, critical insights and fostering stronger collaboration and transparency. Learn more about Adam's presentation, here: https://hubs.ly/Q02Y-BdG0

Every moment reduced in vein-to-vein time gives your autologous CAR-T cell therapy a better chance to do precisely what you designed it to do. Leveraging DAR-T™ from Resilience, you can cut your manufacturing time down to just 3 days – all while capitalizing on the potency and persistence of both naïve and central memory T cells. To see if our DAR-T offering could be a good fit for your program, begin with a quick read here: https://hubs.ly/Q02Z5mHR0 #Biomanufacturing #Resilience

Earlier this week, our San Diego facility opened its doors to a group of biopharma leaders during the Biomanufacturing World Conference to showcase our cutting-edge capabilities in the development and manufacturing of life-saving therapies. The tour provided an opportunity for our colleagues to discover how we integrate advanced technical capabilities with manufacturing to expedite the delivery of therapies, see our state-of-the-art facility, including our cell therapy development spaces, and interact with our technical and scientific experts. Thank you to all those who joined us for the open house! If you weren’t able to attend the tour, be sure to stop by to see our team at the conference this week at booth #21.

Hello San Diego! We can’t wait to see you this week at Biomanufacturing World Summit.  Stop by to see us at booth #21 to learn how we can help solve your development and manufacturing challenges across biologics, vaccines, cell therapy, and gene therapy modalities.  #BMWS24

You've committed significant time, resources, and passion to build a solid foundation for your product. Now, we’re ready to help you define the next steps. Our Alachua, FL, Boston, MA, and Toronto, Canada sites have combined decades of experience and bioreactors up to 2KL to support your scale-up efforts to help your program reach its next milestone. Discover how our built-in regulatory guidance and nimble capabilities combined with the depth and breadth of services our facilities offer can support the growth of your program from a small sprout, all the way to market.  Learn more today: https://hubs.ly/Q02X0Vsp0

We hold a unique industry sweet spot: we’re big enough to partner on your boldest projects, but small enough to provide the kind of service and agility that you wouldn’t typically expect from a conventional CDMO. At Resilience, we build drug substance manufacturing programs that grow with you.   Our Boston facility, situated in the tech hub just off the Harvard Business School Campus, offers process and analytical development and up to 10x 2,000L drug substance manufacturing capacity, available now, to bring life-changing therapies to patients faster, more efficiently, and at the scale, or scale-up you need. Learn more about how our Boston site couples decades of experience with dedicated project management, regulatory support, and integrated fill/finish processes: https://hubs.ly/Q02YgcHg0

Join Evan Pasenello, Debleena Dasgupta, Uzair Beg, and Christina Bevilacqua, tomorrow at Biomanufacturing World Summit! They are excited to engage with industry leaders, share insights, and build new connections. Be sure to stop by to see them at booth #21. We’re also hosting a site tour of our San Diego facility on November 19 during Welcome Day activities—an excellent opportunity to see our work firsthand. Don’t miss our key sessions: 🔹 Pat Yang will participate on November 21 at 2:55 PM PT in a panel discussion: "Reflecting on the Past, Envisioning the Future: Shaping the Future Landscape of Biomanufacturing." 🔹 Lisa Sykes-Winstead MBA, MSc, CQA will present on November 21 at 12:35 PM PT during the lunch session: "Modernizing the Pharma Quality System: What is It and Does It Drive Results?" Connect with us at #BMWS24! Schedule your meeting today: https://hubs.ly/Q02YgvGN0

At Resilience, we understand the challenges you face in the drug development and manufacturing journey. Here are three ways we support our partners: 💪 Room to grow: Our drug substance facilities, all located within North America, offer bioreactors up to 2KL to support your scale-up, with capacity available now. 📍 End-to-end capabilities: With dedicated project management for the life of your program, regulatory support, and integrated fill/finish. ⚖️ Nimble support: We hold a unique industry sweet spot – big enough to partner on your boldest projects, small enough to provide the tailored attention you need. Ready to learn more? Check out our recent Outsourced Pharma Capacity Webinar focused on large molecule drug substance to discover how we can help your nurture your drug substance from a small sprout all the way to market: https://hubs.ly/Q02X0WPn0

During an informative roundtable hosted in partnership with Fierce Pharma, our panel of experts discussed key steps in the vaccine scale-up journey. Dr. Doris Snow, Dr. Isabel Scholz, Justin L. Batte, PhD, and moderator Tarek Abdel-Gawad delved into challenges related to bioreactors, drug substance manufacturing, tech transfers, regulatory compliance, and more. If you missed the live webinar, it’s not too late! Access the on-demand version at your convenience to discover how to navigate vaccine development to the global market and why Resilience could be the right CDMO to support your next program.   Watch now: https://hubs.ly/Q02WPkXg0